Liver transplantation under cyclosporine: a decade of experience.
作者信息
Gordon R D, Todo S, Tzakis A G, Fung J J, Stieber A, Staschak S M, Iwatsuki S, Starzl T E
机构信息
Department of Surgery, University of Pittsburgh, Pennsylvania 15213.
出版信息
Transplant Proc. 1991 Feb;23(1 Pt 2):1393-6.
Abstract
摘要
相似文献
1
Liver transplantation under cyclosporine: a decade of experience.环孢素下的肝移植：十年经验
Transplant Proc. 1991 Feb;23(1 Pt 2):1393-6.
2
Incidence and treatment of rejection episodes in primary orthotopic liver transplantation under FK 506.FK506 作用下原位肝移植术后排斥反应的发生率及治疗情况
Transplant Proc. 1991 Feb;23(1 Pt 2):928-30.
3
Conversion of liver allograft recipients from cyclosporine to FK 506-based immunosuppression: benefits and pitfalls.肝移植受者从环孢素转换为基于FK 506的免疫抑制：益处与风险。
Transplant Proc. 1991 Feb;23(1 Pt 1):14-21.
4
Positive crossmatch in primary human liver allografts under cyclosporine or FK 506 therapy.在环孢素或FK 506治疗下原发性人肝同种异体移植中的阳性交叉配型
Transplant Proc. 1991 Feb;23(1 Pt 1):396-9.
5
Use of FK 506 in pediatric patients.FK506在儿科患者中的应用。
Transplant Proc. 1991 Feb;23(1 Pt 2):924-7.
6
Real-World Multicenter Experience of Immunosuppression Minimization Among 661 Liver Transplant Recipients.661例肝移植受者免疫抑制最小化的真实世界多中心经验
Ann Transplant. 2017 May 2;22:265-275. doi: 10.12659/aot.902523.
7
Maintenance immunosuppression for adults undergoing liver transplantation: a network meta-analysis.肝移植成年受者的维持性免疫抑制：一项网状Meta分析。
Cochrane Database Syst Rev. 2017 Mar 31;3(3):CD011639. doi: 10.1002/14651858.CD011639.pub2.
8
A cost comparison of liver transplantation with FK 506 or CyA as the primary immunosuppressive agent.以FK 506或环孢素A作为主要免疫抑制剂的肝移植成本比较。
Transplant Proc. 1990 Feb;22(1):47-9.
9
Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications.肝移植受者中因环孢素相关并发症而从环孢素转换为FK506治疗。
Transplant Proc. 1990 Feb;22(1):6-12.
10
Transplantation's newest weapon FK 506.
Am J Nurs. 1991 Oct;91(10):40-2.
引用本文的文献
1
Outcome after Liver Transplantation for Cystic Fibrosis.囊性纤维化患者肝移植后的结局
Pediatr Pulmonol Suppl. 1991;11(S1):130-131.
2
Long-term survival after liver transplantation in 4,000 consecutive patients at a single center.单中心4000例连续肝移植患者的长期生存情况。
Ann Surg. 2000 Oct;232(4):490-500. doi: 10.1097/00000658-200010000-00004.
3
What have we learned about primary liver transplantation under tacrolimus immunosuppression? Long-term follow-up of the first 1000 patients.关于在他克莫司免疫抑制下进行的原位肝移植，我们了解到了什么？对首批1000例患者的长期随访。
Ann Surg. 1999 Sep;230(3):441-8; discussion 448-9. doi: 10.1097/00000658-199909000-00016.
4
Should liver transplantation be performed before advanced renal insufficiency in primary hyperoxaluria type 1?1型原发性高草酸尿症患者在出现晚期肾功能不全之前是否应进行肝移植？
Pediatr Nephrol. 1993 Apr;7(2):212-8; discussion 218-9. doi: 10.1007/BF00864408.
5
Combined liver-kidney transplantation and the effect of preformed lymphocytotoxic antibodies.肝肾联合移植及预先形成的淋巴细胞毒性抗体的影响
Transpl Immunol. 1994;2(1):61-7. doi: 10.1016/0966-3274(94)90080-9.
6
7
Recent advances in hepatic transplantation at the University of Pittsburgh.匹兹堡大学肝脏移植的最新进展。
Clin Transpl. 1993:137-52.
8
Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation.他克莫司。其药理学及在肝移植和肾移植中的治疗潜力综述。
Drugs. 1993 Oct;46(4):746-94. doi: 10.2165/00003495-199346040-00009.
本文引用的文献
1
B hepatitis and liver transplantation.乙型肝炎与肝移植
Transplant Proc. 1988 Feb;20(1 Suppl 1):566-9.
2
Experience in 1,000 liver transplants under cyclosporine-steroid therapy: a survival report.1000例接受环孢素-类固醇治疗的肝移植经验：一份生存报告。
Transplant Proc. 1988 Feb;20(1 Suppl 1):498-504.
3
TIMY--a center-oriented transplant information management system.TIMY——一个以中心为导向的移植信息管理系统。
Transplant Proc. 1988 Feb;20(1 Suppl 1):385-90.
4
Orthotopic liver transplantation for alcoholic cirrhosis.酒精性肝硬化的原位肝移植
JAMA. 1988 Nov 4;260(17):2542-4.
5
Immunoprophylaxis of hepatitis B virus reinfection in recipients of human liver allografts.人肝移植受者乙肝病毒再感染的免疫预防
Transplant Proc. 1987 Feb;19(1 Pt 3):2387-9.
6
Liver Transplant Registry Report.肝移植登记报告。
Transplant Proc. 1991 Feb;23(1 Pt 1):58-60.
Zotero 插件